Searched for
KOTESWARA RAO
No more painful insulin shots: Hyderabad company develops oral insulin spray for diabetesHyderabad-based NiedlFree Technologies has developed a needle-free oral insulin spray called Ozulin, offering a painless alternative for di...- Bhatlapenumarru: A small Andhra village remembers its son who designed the national flagA two-story building built a few years ago with money pooled by the villagers and some philanthropists, which is used mostly as a community...
- Ram Temple Trust, RSS offshoots to begin massive donation driveIn Uttar Pradesh, on a block level, 35 teams of about six people each will be deployed, with one deposit collector for four teams. Joint ge...
- Visakhapatnam homes now turn ‘smart’ with Internet-linked devicesAs per NASSCOM, the number of IoT devices in India is expected to increase significantly from 200 million units in 2016 to 2.7 billion unit...
- Sell LIC Housing Finance, target Rs 465: Manas JaiswalSell LIC Housing Finance Ltd. at a price target of Rs 465.0 and a stoploss at Rs 496 from entry point.
- Sell LIC Housing Finance, target Rs 527: Dr CK NarayanSell LIC Housing Finance Ltd. at a price target of Rs 527.0 and a stoploss at Rs 540 from entry point.
- IDBI Bank employees oppose proposed take over by LICTaking into consideration the fact that the bank has been consecutively posting healthy operating profits, burgeoning provisioning to NPAs ...
- Sell LIC Housing Finance, target Rs 470: Manas JaiswalSell LIC Housing Finance Ltd. at a price target of Rs 470.0 and a stoploss at Rs 501 from entry point.
- Sell Divi's Laboratories, target Rs 475.0 : Manas JaiswalSell Divi's Laboratories Ltd. at a price target of Rs 475.0 and a stop loss at Rs 606.0 from entry point
- Buy Divi's Laboratories, target Rs 678: Siddharth BhamreBuy Divi's Laboratories Ltd. at a price target of Rs 678.0 and a stop loss at Rs 609.0 from entry point
- Buy Divi's Laboratories Ltd. target Rs 660.0 : Sarvendra SrivastavaBuy Divi's Laboratories Ltd. at a price target of Rs 660.0 and a stoploss at Rs 618.4 from entry point
- India supports instrument on conservation of biodiversity"It should address issues relating to the access, exploration, exploitation, conservation and sustainable use of these resources," he added.
- Transgene alleges $38 million fraud by Nirmal Kotecha, aidesCity-based Transgene Biotek has accused the known securities market offender Nirmal Kotecha of duping it to the tune of around $38.42 milli...
- Hiding behind Mars, MOM captures comet Siding SpringIsro chairman Radhakrishnan said: "We expect to cover the comet Siding Spring in three phases: before its approach, during its flypast & af...
- ISRO team presents first MOM pictures of Mars to PM Narendra ModiThe team, led by ISRO Chairman K Radhakrishnan and ISRO Scientific Secretary V Koteswara Rao, flew in here to hand over to pictures to the ...
- Prime Minister Narendra Modi to witness Mars Orbiter Insertion at ISRO facilityMars Orbiter Insertion (MOI) operation of the spacecraft is scheduled to be performed on September 24 at 07:17:32 hrs IST.
- Mars Orbiter Mission: Mangalyan to send colour images of Mars from WednesdayThe images, once transmitted will be received by Isro's Indian Deep Space Network (IDSN) in Byalalu, Karnataka.
- ISRO all set for trans-Mars injection on December 1ISRO has also planned four mid-course corrections in case of any deviation along its path to Martian orbit.
- Transgene Biotek to delist from Indian stock exchangesBiotechnology firm Transgene Biotek today said that its board of directors has decided to delist its shares from Indian stock exchanges.
- We are looking at acquisitions: MD, Transgene BiotekET Now caught up with Dr. K Koteswara Rao, CMD, Transgene Biotek Ltd, for his views on company's growth and future strategy. Excerpts:
Load More
